These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25187155)

  • 21. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A signal detection method to detect adverse drug reactions using a parametric time-to-event model in simulated cohort data.
    Cornelius VR; Sauzet O; Evans SJ
    Drug Saf; 2012 Jul; 35(7):599-610. PubMed ID: 22702641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From pharmacovigilance to pharmacoepidemiology and risk coordination].
    Montastruc JL
    Rev Med Interne; 2009 Dec; 30 Suppl 4():S281-90. PubMed ID: 19892443
    [No Abstract]   [Full Text] [Related]  

  • 24. vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.
    Caster O; Sandberg L; Bergvall T; Watson S; Norén GN
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):1006-1010. PubMed ID: 28653790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.
    Khouri C; Revol B; Lepelley M; Mouffak A; Bernardeau C; Salvo F; Pariente A; Roustit M; Cracowski JL
    J Clin Epidemiol; 2021 Nov; 139():191-198. PubMed ID: 34329725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
    Jiang JJ; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.
    Lee I; Lee TA; Crawford SY; Kilpatrick RD; Calip GS; Jokinen JD
    Expert Opin Drug Saf; 2020 Oct; 19(10):1357-1366. PubMed ID: 32662668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions in neonates: could we be documenting more?
    Hawcutt DB; O'Connor O; Turner MA
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of an active pharmacovigilance system carried out by a pharmacist].
    Sánchez I; Amador C; Plaza JC; Correa G; Amador R
    Rev Med Chil; 2014 Aug; 142(8):998-1005. PubMed ID: 25424672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse drug reactions and prescription errors: morbi-mortality].
    Chaio S; Toibaro J; Valicenti P; Saidón P
    Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?
    Pacurariu AC; Hoeve CE; Arlett P; Genov G; Slattery J; Sturkenboom MCJM; Straus SMJM
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):168-173. PubMed ID: 29278866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uses of pharmacovigilance databases: An overview.
    Bihan K; Lebrun-Vignes B; Funck-Brentano C; Salem JE
    Therapie; 2020; 75(6):591-598. PubMed ID: 32169289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.
    Maro JC; Brown JS; Dal Pan GJ; Kulldorff M
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):839-48. PubMed ID: 24700557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.
    Uddin MJ; Groenwold RH; van Staa TP; de Boer A; Belitser SV; Hoes AW; Roes KC; Klungel OH
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):468-77. PubMed ID: 25410590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands.
    Rolfes L; Kolfschoten J; van Hunsel F; Kooijman M; van Puijenbroek E
    Int J Risk Saf Med; 2016 Aug; 28(2):115-23. PubMed ID: 27567768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
    Laroche ML; Perault-Pochat MC; Ingrand I; Merle L; Kreft-Jais C; Castot-Villepelet A; Durrieu G; Gras V; Guy C; Jean-Pastor MJ; Jonville-Béra AP; Merlet-Chicoine I; Miremont-Salamé G; Nourhashemi F; Charmes JP;
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):952-60. PubMed ID: 23794320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validity and reliability of a signal impact assessment tool.
    Rolfes L; Kolfschoten J; van Hunsel F; van Puijenbroek E
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):815-9. PubMed ID: 27193557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical Signal Detection as a Routine Pharmacovigilance Practice: Effects of Periodicity and Resignalling Criteria on Quality and Workload.
    Lerch M; Nowicki P; Manlik K; Wirsching G
    Drug Saf; 2015 Dec; 38(12):1219-31. PubMed ID: 26391801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.